Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson's disease: a longitudinal study.
Jingjie GeMin WangWei LinPing WuYihui GuanHuiwei ZhangZhemin HuangLikun YangChuan-Tao ZuoJie-Hui JiangAxel RomingerKuangyu ShiPublished in: EJNMMI research (2020)
The preliminary results demonstrate the potential of metabolic network expression as complimentary objective biomarker for the assessment and monitoring of STN DBS treatment in PD patients. Clinical Trial Registration ChiCTR-DOC-16008645. http://www.chictr.org.cn/showproj.aspx?proj=13865 .
Keyphrases
- deep brain stimulation
- parkinson disease
- clinical trial
- end stage renal disease
- obsessive compulsive disorder
- newly diagnosed
- ejection fraction
- chronic kidney disease
- poor prognosis
- prognostic factors
- squamous cell carcinoma
- randomized controlled trial
- combination therapy
- double blind
- patient reported outcomes
- climate change
- long non coding rna
- patient reported